Shopping Cart 0
Cart Subtotal
USD 0

Galderma SA-Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Galderma SA-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-GlobalData's summarization of the company's business strategy.

SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Highlights

Galderma SA (Galderma) is a pharmaceutical company. It develops and markets drugs, medical dermatology solutions and therapeutic skin care products for the treatment of hair, nail, and skin diseases. Galderma offers products for the treatment of skin conditions such as seborrheic dermatitis, androgenetic alopecia, glabellar lines, dry skin, acne, psoriasis, atopic dermatitis and steroid responsive dermatoses, onychomycosis, rosacea, and skin cancer. The company offers products leading brands such as Azzalure, Cetaphil, Clobex, Macrolane, and Oracea among several others. It markets products in India, Greece, Italy, Canada, Chile, Poland, the UK, and the US, among others. The company operates manufacturing facilities in France, Sweden, Canada, Brazil, Germany and Switzerland and research and development (R&D) centers in France, Sweden, the United States, Switzerland and Japan. Galderma is headquartered in Lausanne, Switzerland.

Galderma SA Key Recent Developments

Dec 20,2016: Appointment of Nestle Skin Health CEO ad interim

Jul 20,2016: Maruho and Galderma Strengthen Strategic Alliance in Japan

Jun 10,2016: Galderma Celebrates 20th Global Anniversary of Restylane

Feb 05,2016: Galderma, worldwide leader in Dermatology, has just announced that their R&D site in Sophia Antipolis-France has been granted the AFNOR ISO 22301 certification

Reasons to Buy

Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Galderma SA-Key Facts 5

Galderma SA-Key Employees 6

Galderma SA-Major Products and Services 7

Galderma SA-Pharmaceutical Pipeline Products Data 9

Galderma SA, Pipeline Products by Therapy Area 9

Galderma SA, Pipeline Products by Development Phase 9

Galderma SA-History 11

Galderma SA-Company Statement 14

Galderma SA-Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2-Company Analysis 18

Galderma SA-Business Description 18

Galderma SA-SWOT Analysis 19

SWOT Analysis-Overview 19

Galderma SA-Strengths 19

Galderma SA-Weaknesses 20

Galderma SA-Opportunities 21

Galderma SA-Threats 22

Galderma SA-Key Competitors 23

Section 3-Company's Lifesciences Financial Deals and Alliances 24

Galderma SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 24

Galderma SA, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 26

Galderma SA, Recent Deals Summary 27

Section 4-Company's Recent Developments 28

Dec 20, 2016: Appointment of Nestle Skin Health CEO ad interim 28

Jul 20, 2016: Maruho and Galderma Strengthen Strategic Alliance in Japan 29

Jun 10, 2016: Galderma Celebrates 20th Global Anniversary of Restylane 30

Feb 05, 2016: Galderma, worldwide leader in Dermatology, has just announced that their R&D site in Sophia Antipolis-France has been granted the AFNOR ISO 22301 certification 31

Section 5-Appendix 32

Methodology 32

About GlobalData 32

Contact Us 32

Disclaimer 32


List Of Figure

List of Figures

Galderma SA, Pipeline Products by Therapy Area 9

Galderma SA, Pipeline Products by Development Phase 9

Galderma SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 24

Galderma SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 26


List Of Table

List of Tables

Galderma SA, Key Facts 5

Galderma SA, Key Employees 6

Galderma SA, Major Products and Services 7

Galderma SA, Number of Pipeline Products by Development Stage 10

Galderma SA, History 11

Galderma SA, Other Locations 15

Galderma SA, Subsidiaries 15

Galderma SA, Key Competitors 23

Galderma SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 24

Galderma SA, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 26

Galderma SA, Recent Deals Summary 27

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Galderma SA, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.


Companies

Pantec Biosolutions AG Merz Aesthetics Inc Mentor Worldwide LLC Maruho Co Ltd G.L. Pharma GmbH Almirall Hermal GmbH